2015 ISAKOS Biennial Congress Paper #0

Plication For Intra-Operatively Confirmed Microinstability: How Well Does It Work?

Catherine J. Bacon, PhD, MSc, BSc, BPhed(Hons), Auckland NEW ZEALAND
Rowan Auchterlonie NEW ZEALAND
Man Lu, MD PhD, Auckland NEW ZEALAND
Abbey C. Lissaman, Auckland NEW ZEALAND
Gen Lin Foo, MD, Singapore, Singapore SINGAPORE
Rebecca Woodward, MBChB, FRANZCR, Auckland NEW ZEALAND
Matthew J. Brick, MBChB, FRACS, Auckland NEW ZEALAND

Orthosports North Harbour Limited, Auckland, Auckland, NEW ZEALAND

FDA Status Not Applicable

Summary: In a consecutive sample of hip arthroscopy patients with intra-operatively confirmed microinstability, those treated with plication showed reduced symptoms and improved quality-of-life compared to no plication.

Rate:

Abstract:

Background

There is growing consensus that intra-operative confirmation of hip microinstability is the gold standard diagnosis. Surgical treatment entails plication to reduce compliance of hip capsular ligaments, but few studies have analysed longer term outcomes.

Purpose

To compare outcomes of arthroscopy patients with hip microinstability who received capsular plication with those who did not, using consecutive sampling of a large single-surgeon cohort.

Methods

We reviewed our prospective database for primary hip arthroscopies undertaken between 2009 and 2020 with intra-operative indications of hip microinstability. Criteria included either ease of distraction of the hip, an isolated straight anterior labral tear, inside-out chondral lesion, or a lateral labral tear in the absence of cam or pincer morphology, with any one of these confirming diagnosis. Those who received plication were compared with those who did not. Patient-reported outcomes included International Hip Outcome Tool (iHOT12), Hip Disability and Osteoarthritis Scores (HOOS) and patient satisfaction with minimum 2-year follow-up. Surgical outcomes were 2-year rates of subsequent ipsilateral hip joint surgery, with incidence of conversion to arthroplasty obtained from a national register.

Results

A total of 271 hips (240 patients) aged 31.5±10.9 years (mean±SD), 253 (93%) female, were included in this analysis, of which 207 (76%) received plication. Though pre-operative to follow-up change in iHOT12 did not differ statistically between treatment groups (plication increased from 29±15 to 67±26 versus non-plication from 31±14 to 63±29), both HOOS-symptoms and -quality-of-life subscores improved more in those undergoing plication compared to non-plication (HOOS-symptoms from 53±18 to 75±19 versus 56±17 to 71±19, p=0.03; and HOOS-quality-of-life from 27±16 to 63±24 versus 31±16 to 56±27, p=0.02). Of those who had the plication procedure, 87% of patients indicated that they definitely (47%) or probably (40%) would have the surgery again, compared with 80% (53% definitely and 28% probably) of those with no plication, though group differences were not statistically significant. The overall 2-year rate of revision surgery (1.8%) and arthroplasty conversion (1.1%) was not different between groups.

Conclusion

Data from this large sample confirm that hip microinstability can be successfully treated with plication, particularly in reducing unwanted symptoms and improving overall quality of life.